Dubai: The Higher Committee for the Monitoring and Review of Schedules of Narcotic and Psychotropic Substances of the Ministry of Health and Prevention (MOHAP) has added atomoxetine to the list of controlled medicines.
Atomoxetine is a norepinephrine, noradrenaline, reuptake inhibitor which is approved for the treatment of attention deficit hyperactivity disorder (ADHD).
Dr Ameen Hussain Al Amiri, assistant undersecretary of MOHAP for Public Health Policy and Licences and chairman of the higher committee, chaired a meeting of the committee on Thursday, where officials from the Federal Drug Control Authority, the Department of Criminal Evidence of Dubai Police, Dubai Courts, Sharjah Courts, Dubai Police, Abu Dhabi Health Department (Haad), and Department of Criminal Evidence of Abu Dhabi Police were also present.
Al Amiri stressed the ministry’s keenness on working with the competent authorities across the country for protecting the community against narcotic and psychotropic substances that cause a lot of health and social problems.
By fulfilling all its commitments, as per the international agreements, the UAE has become one of the top countries worldwide concerning narcotic and psychotropic substances control.